Anzeige
Mehr »
Login
Sonntag, 21.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Breaking News: Voller Fokus auf NurExone Biologic!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QD8U | ISIN: US87650L1035 | Ticker-Symbol:
NASDAQ
19.04.24
21:59 Uhr
32,440 US-Dollar
-0,410
-1,25 %
1-Jahres-Chart
TARSUS PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
TARSUS PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur TARSUS PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.03.Tarsus Pharmaceuticals exec sells over $135k in stock1
20.03.Tarsus Pharmaceuticals CCO sells shares worth over $145k2
20.03.Tarsus Pharmaceuticals CEO sells shares worth over $318k1
20.03.Tarsus Pharmaceuticals executive sells over $130k in company stock1
12.03.Tarsus launches a 'Mite Party' for new Xdemvy marketing campaign2
06.03.Jefferies raises Tarsus Pharma stock target to $44 on strong launch1
05.03.Tarsus Pharmaceuticals, Inc: Tarsus to Participate at Upcoming Investor Conferences1
05.03.Tarsus Pharmaceuticals, Inc. - 8-K, Current Report1
05.03.Tarsus Pharmaceuticals, Inc: Tarsus Introduces "Mite Party" Campaign for XDEMVY (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis114Unique and memorable campaign intended to educate consumers about Demodex blepharitis and XDEMVY, the first and only FDA approved solution for the disease Demodex blepharitis impacts approximately...
► Artikel lesen
04.03.Tarsus Redefines Financial Strategy by Combining Innovative Outsourced Accounting, CFO, Finance, and Transaction Services323WASHINGTON, DC / ACCESSWIRE / March 4, 2024 / Tarsus, a trailblazing accounting, financial, and transaction services firm, is proud to announce its official re-branding and expanding industry and service...
► Artikel lesen
01.03.Tarsus Pharma slides on $100 million stock offering1
01.03.Tarsus Pharmaceuticals sets $32 stock offering price1
01.03.Tarsus Pharmaceuticals stock dips after pricing $100M securities offering1
01.03.Tarsus Pharmaceuticals, Inc: Tarsus Announces Pricing of $100.0 Million Public Offering2
29.02.Tarsus announces proposed $100M public offering1
29.02.Tarsus Pharmaceuticals launches $100 million stock offering1
29.02.Tarsus Pharmaceuticals files for automatic mixed securities shelf1
29.02.Tarsus Pharmaceuticals, Inc: Tarsus Announces Proposed $100.0 Million Public Offering1
29.02.A Glimpse Into The Expert Outlook On Tarsus Pharmaceuticals Through 4 Analysts1
27.02.Tarsus Pharmaceuticals, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
Seite:  Weiter >>
49 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1